ArticleCancer research and treatment2022

Assessment of Anti-tumor Efficacy of Osimertinib in Non-Small Cell Lung Cancer Patients by Liquid Biopsy Using Bronchoalveolar Lavage Fluid, Plasma, or Pleural Effusion.

Yeon Joo Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.